Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Katsuhiro Ohyama, Norie Murayama, Makiko Shimizu & Hiroshi Yamazaki. (2014) Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation. Xenobiotica 44:1, pages 10-16.
Read now
Read now
Srinivas Lankalapalli & Ramana Murthy Kolapalli. (2012) Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya − chitosan polyelectrolyte complexes. Drug Development and Industrial Pharmacy 38:7, pages 815-824.
Read now
Read now
Işik Özgüney. (2008) An alternative topical treatment of osteoarthritis of the knee with cutaneous diclofenac solution. Expert Opinion on Pharmacotherapy 9:10, pages 1805-1816.
Read now
Read now
Kay Brune. (2007) Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Current Medical Research and Opinion 23:12, pages 2985-2995.
Read now
Read now
Meena Rani, Rahul Surana, C. Sankar & B. Mishra. (2004) Formulation and Biopharmaceutical Evaluation of Osmotic Matrix Tablets of Diclofenac Sodium. Drug Delivery 11:4, pages 263-270.
Read now
Read now
Fergany A. Mohammed. (2001) Topical Permeation Characteristics of Diclofenac Sodium from NaCMC Gels in Comparison with Conventional Gel Formulations. Drug Development and Industrial Pharmacy 27:10, pages 1083-1097.
Read now
Read now
B. Arica, H. S. Kaş, A. A. Hincal, M. Y. Arica & V. Hasirci. (1996) In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres. Journal of Microencapsulation 13:6, pages 689-699.
Read now
Read now
Toshiaki Nishihata, Ayumi Tsutsumi, Chie Ikawa & Kiyoshi Sakai. (1990) Sustained Release Suppository of Sodium Diclofenac: use of Water Absorbable Polymer. Drug Development and Industrial Pharmacy 16:10, pages 1675-1686.
Read now
Read now
Peter H. Degen, Walter Dieterle, Werner Schneider, Walter Theobald & Ursula Sinterhauf. (1988) Pharmacokinetics of Diclofenac and Five Metabolites After Single Doses in Healthy Volunteers and After Repeated Doses in Patients. Xenobiotica 18:12, pages 1449-1455.
Read now
Read now
KeithK. H. Chan & KunjbalaH. Vyas. (1985) Determination of Diclofenac Sodium in Synovial Fluid by High Performance Liquid Chromatography. Analytical Letters 18:20, pages 2507-2519.
Read now
Read now
I.
Monika Johansson & Marie-Louise Eklund. (1984) Liquid Chromatographic Determination of Meclofenamic Acid In Equine Plasma. Journal of Liquid Chromatography 7:8, pages 1609-1626.
Read now
Read now
Jarkko Haapasaari, Erkki Wuolijoki & Heikki Ylijoki. (1983) Treatment of Juvenile Rheumatoid Arthritis with Diclofenac Sodium. Scandinavian Journal of Rheumatology 12:4, pages 325-330.
Read now
Read now
Jack Kutti & Anna-Lisa Bergström. (1981) Platelet Kinetics in Systemic Lupus Erythematosus (SLE), with Special Reference to Corticosteroid and Azathioprine Therapy. Scandinavian Journal of Rheumatology 10:4, pages 266-268.
Read now
Read now
Anna-Lisa Bergström, Lars-Bertil Olsson & Jack Kutti. (1980) Platelet Survival and Platelet Production in Systemic Lupus Erythematosus (SLE). Scandinavian Journal of Rheumatology 9:4, pages 209-215.
Read now
Read now
H. Stierlin & J. W. Faigle. (1979) Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 9:10, pages 611-621.
Read now
Read now
H. Stierlin, J. W. Faigle, A. Sallmann, W. Kung, W. J. Richter, H.-P. Kriemler, K. O. Alt & T. Winkler. (1979) Biotransformation of diclofenac sodium (Voltaren®) in animals and in man. Xenobiotica 9:10, pages 601-610.
Read now
Read now
J. V. Willis & M. J. Kendall. (1978) Pharmacokinetic Studies on Diclofenac Sodium in Young and Old Volunteers. Scandinavian Journal of Rheumatology 7:sup22, pages 36-41.
Read now
Read now
R. Menassé, P. R. Hedwall, J. Kraetz, C. Pericin, L. Riesterer, A. Sallmann, R. Ziel & R. Jaques. (1978) Pharmacological Properties of Diclofenac Sodium and Its Metabolites. Scandinavian Journal of Rheumatology 7:sup22, pages 5-16.
Read now
Read now
Articles from other publishers (97)
Maximilian M. Menger, Maximilian Stief, Claudia Scheuer, Mika F. Rollmann, Steven C. Herath, Benedikt J. Braun, Sabrina Ehnert, Andreas K. Nussler, Michael D. Menger, Matthias W. Laschke & Tina Histing. (2023) Diclofenac, a NSAID, delays fracture healing in aged mice. Experimental Gerontology 178, pages 112201.
Crossref
Crossref
Vivian Rodriguez‐Cruz, Tianjing Ren & Marilyn E. Morris. (2021) Drug‐drug interaction between diclofenac and gamma‐hydroxybutyric acid. Biopharmaceutics & Drug Disposition 42:8, pages 351-358.
Crossref
Crossref
Nada Božina, Lana Ganoci, Livija Simičević, Katarina Gvozdanović, Iva Klarica Domjanović, Margareta Fistrek Prlić, Tena Križ, Ana Borić Bilušić, Mario Laganović & Tamara Božina. (2021) Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review. Archives of Industrial Hygiene and Toxicology 72:2, pages 114-128.
Crossref
Crossref
Jianfa Gao, Benjamin J. Tscharke, Phil M. Choi, Jake W. O’Brien, Tim Boogaerts, Hui Jiang, Mengting Yang, Samantha A. Hollingworth & Phong K. Thai. (2021) Using Prescription and Wastewater Data to Estimate the Correction Factors of Atenolol, Carbamazepine, and Naproxen for Wastewater-Based Epidemiology Applications. Environmental Science & Technology 55:11, pages 7551-7560.
Crossref
Crossref
Andreas Hartmann, Linda Erkman, Nihal Maremanda, Azeddine Elhajouji & Hans-Joerg Martus. (2021) Comprehensive review of genotoxicity data for diclofenac. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 866, pages 503347.
Crossref
Crossref
Daniel Zakowiecki, Maja Frankiewicz, Tobias Hess, Krzysztof Cal, Maciej Gajda, Justyna Dabrowska, Bartlomiej Kubiak, Jadwiga Paszkowska, Marcela Wiater, Dagmara Hoc, Grzegorz Garbacz & Dorota Haznar-Garbacz. (2021) Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets. Pharmaceutics 13:6, pages 805.
Crossref
Crossref
Sharad Sheth, Sneha Thakur, Anup Thorat & Pankaj Gupta. (2021) Safe and appropriate use of diclofenac in chronic kidney disease: An Indian perspective. Journal of Family Medicine and Primary Care 10:7, pages 2450.
Crossref
Crossref
Pramod Kumar Goswami, Vineet Kumar & Arunachalam Ramanan. (2020) Multicomponent solids of diclofenac with pyridine based coformers. Journal of Molecular Structure 1210, pages 128066.
Crossref
Crossref
Tae Young Park, Hyoung-Chul Oh, Evan L. Fogel & Glen A. Lehman. (2020) Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs. The Korean Journal of Internal Medicine 35:3, pages 535-543.
Crossref
Crossref
Renato J. Scialis, Lauren M. Aleksunes, Iván L. Csanaky, Curtis D. Klaassen & José E. Manautou. (2019) Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites. Drug Metabolism and Disposition 47:10, pages 1080-1092.
Crossref
Crossref
Nina Mertz, Jesper Østergaard, Anan Yaghmur & Susan Weng Larsen. (2019) Transport characteristics in a novel in vitro release model for testing the performance of intra-articular injectables. International Journal of Pharmaceutics 566, pages 445-453.
Crossref
Crossref
Mette Thing, Nina Mertz, Li Ågårdh, Susan Weng Larsen, Jesper Østergaard & Claus Larsen. (2019) Simulated synovial fluids for in vitro drug and prodrug release testing of depot injectables intended for joint injection. Journal of Drug Delivery Science and Technology 49, pages 169-176.
Crossref
Crossref
Biljana Gatarić & Jelena Parojčić. (2019) Application of data mining approach to identify drug subclasses based on solubility and permeability. Biopharmaceutics & Drug Disposition 40:2, pages 51-61.
Crossref
Crossref
C. E. Wilson, A. P. Dickie, K. Schreiter, R. Wehr, E. M. Wilson, J. Bial, N. Scheer, I. D. Wilson & R. J. Riley. (2018) The pharmacokinetics and metabolism of diclofenac in chimeric humanized and murinized FRG mice. Archives of Toxicology 92:6, pages 1953-1967.
Crossref
Crossref
Maria M. Posada, Ellen A. Cannady, Christopher D. Payne, Xin Zhang, James A. Bacon, Y. Anne Pak, J. William Higgins, Nazila Shahri, Stephen D. Hall & Kathleen M. Hillgren. (2017) Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib. Clinical and Translational Science 10:6, pages 509-519.
Crossref
Crossref
Atsushi Kawase, Ryota Hashimoto, Mai Shibata, Hiroaki Shimada & Masahiro Iwaki. (2017) Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes. International Journal of Toxicology 36:3, pages 260-267.
Crossref
Crossref
Bénilde Bonnefille, Lauren Arpin-Pont, Elena Gomez, Hélène Fenet & Frédérique Courant. (2017) Metabolic profiling identification of metabolites formed in Mediterranean mussels ( Mytilus galloprovincialis ) after diclofenac exposure. Science of The Total Environment 583, pages 257-268.
Crossref
Crossref
Chung-Ping Yu, Douglas H. Sweet, Yu-Hsuan Peng, Yow-Wen Hsieh, Pei-Dawn Lee Chao, Yu-Chi Hou & Shiuan-Pey Lin. (2017) Effects of nonsteroidal anti-inflammatory drugs on the renal excretion of indoxyl sulfate, a nephro-cardiovascular toxin, in rats. European Journal of Pharmaceutical Sciences 101, pages 66-70.
Crossref
Crossref
Masahiro Iwaki, Hiroaki Shimada, Yuri Irino, Manami Take & Sachiko Egashira. (2017) Inhibition of Methotrexate Uptake <i>via</i> Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:6, pages 926-931.
Crossref
Crossref
Hirotoshi Ishiwatari, Takahiro Urata, Ichiro Yasuda, Shimpei Matsusaki, Hiroyuki Hisai, Hiroshi Kawakami, Michihiro Ono, Takuji Iwashita, Shinpei Doi, Kazumichi Kawakubo, Tsuyoshi Hayashi, Tomoko Sonoda, Naoya Sakamoto & Junji Kato. (2016) No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Digestive Diseases and Sciences 61:11, pages 3292-3301.
Crossref
Crossref
Natan Roberto de Barros, Paulo Augusto Marques Chagas, Felipe Azevedo Borges, Jose Lucio Padua Gemeinder, Matheus Carlos Romeiro Miranda, Bruna Cambraia Garms & Rondinelli Donizetti Herculano. (2015) Diclofenac Potassium Transdermal Patches Using Natural Rubber Latex Biomembranes as Carrier. Journal of Materials 2015, pages 1-7.
Crossref
Crossref
Renato J. Scialis, Iván L. Csanaky, Michael J. Goedken & José E. Manautou. (2015) Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac. Drug Metabolism and Disposition 43:7, pages 944-950.
Crossref
Crossref
Roy Altman, Bill Bosch, Kay Brune, Paola Patrignani & Clarence Young. (2015) Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology. Drugs 75:8, pages 859-877.
Crossref
Crossref
Mette Thing, Li Ågårdh, Susan Larsen, Rune Rasmussen, Jakob Pallesen, Nina Mertz, Jesper Kristensen, Martin Hansen, Jesper Østergaard & Claus Selch Larsen. (2014) A Prodrug Approach Involving In Situ Depot Formation to Achieve Localized and Sustained Action of Diclofenac After Joint Injection. Journal of Pharmaceutical Sciences 103:12, pages 4021-4029.
Crossref
Crossref
Choon Fu Goh & Majella E. Lane. (2014) Formulation of diclofenac for dermal delivery. International Journal of Pharmaceutics 473:1-2, pages 607-616.
Crossref
Crossref
Thomas J. Bateman, Vijay G.B. Reddy, Masakazu Kakuni, Yoshio Morikawa & Sanjeev Kumar. (2014) Application of Chimeric Mice with Humanized Liver for Study of Human-Specific Drug Metabolism. Drug Metabolism and Disposition 42:6, pages 1055-1065.
Crossref
Crossref
Dustin L. Cooper, Robert C. WoodIIIIII, Jarrett E. Wyatt & Sam Harirforoosh. (2014) Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats. European Journal of Pharmaceutical Sciences 53, pages 28-34.
Crossref
Crossref
Nilesh Randive & Richard M. Langford. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology
548
562
.
Sanford H Roth. (2013) Diclofenac in the treatment of osteoarthritis. International Journal of Clinical Rheumatology 8:2, pages 185-203.
Crossref
Crossref
Malin Darnell, Maria Ulvestad, Ewa Ellis, Lars Weidolf & Tommy B. Andersson. (2012) In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System. Journal of Pharmacology and Experimental Therapeutics 343:1, pages 134-144.
Crossref
Crossref
Daniel Mueller, Ursula Müller-Vieira, Klaus M. Biemel, Georg Tascher, Andreas K. Nüssler & Fozia Noor. (2012) Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure. European Journal of Pharmaceutical Sciences 45:5, pages 716-724.
Crossref
Crossref
Kenji Tabata, Kiyoshi Yamaoka, Hiroyuki Yasui, Takako Fukuyama & Terumichi Nakagawa. (1996) Influence of Pentobarbitone on In-vivo Local Disposition of Diclofenac in Rat Liver. Journal of Pharmacy and Pharmacology 48:8, pages 866-869.
Crossref
Crossref
Takako Fukuyama, Kiyoshi Yamaoka, Kenji Tabata & Terumichi Nakagawa. (1996) Inhibitory Effect of Pentobarbital on Biliary Excretion of Diclofenac in a Rat Liver Perfusion System. Journal of Pharmacy and Pharmacology 48:7, pages 734-737.
Crossref
Crossref
H C Atkinson & S B Duffull. (1991) Prediction of drug loss from PVC infusion bags. Journal of Pharmacy and Pharmacology 43:5, pages 374-376.
Crossref
Crossref
Yousry M El-Sayed, Mohamed E Abdel-Hameed, Mohammad S Suleiman & Naji M Najib. (1988) A rapid and sensitive high-performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies. Journal of Pharmacy and Pharmacology 40:10, pages 727-729.
Crossref
Crossref
F. del Nogal Sáez, M.A. Blasco Navalpotro, J. Jiménez Jiménez & F.J. Seoane Leston. (2011) Reacción adversa grave a diclofenaco. Medicina Intensiva 35:3, pages 194-195.
Crossref
Crossref
Nuggehally R. Srinivas & Ramesh Mullangi. (2011) An overview of various validated HPLC and LC-MS/MS methods for quantitation of drugs in bile: challenges and considerations. Biomedical Chromatography 25:1-2, pages 65-81.
Crossref
Crossref
Phatsawee Jansook, Sergey V. Kurkov & Thorsteinn Loftsson. (2010) Cyclodextrins as solubilizers: Formation of complex aggregates. Journal of Pharmaceutical Sciences 99:2, pages 719-729.
Crossref
Crossref
B.Chuasuwan, V. Binjesoh, J.E. Polli, H. Zhang, G.L. Amidon, H.E. Junginger, K.K. Midha, V.P. Shah, S. Stavchansky, J.B. Dressman & D.M. Barends. (2009) Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Diclofenac Sodium and Diclofenac Potassium. Journal of Pharmaceutical Sciences 98:4, pages 1206-1219.
Crossref
Crossref
Dele Stülten, Marc Lamshöft, Sebastian Zühlke & Michael Spiteller. (2008) Isolation and characterization of a new human urinary metabolite of diclofenac applying LC–NMR–MS and high-resolution mass analyses. Journal of Pharmaceutical and Biomedical Analysis 47:2, pages 371-376.
Crossref
Crossref
Nicholas Moore. (2007) Diclofenac Potassium 12.5mg Tablets for Mild to Moderate Pain and Fever. Clinical Drug Investigation 27:3, pages 163-195.
Crossref
Crossref
Nathan K. Evanson. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
7
.
L. De Bartolo, S. Morelli, L. Giorno, C. Campana, M. Rende, S. Salerno, S. Maida & E. Drioli. (2006) Polyethersulfone membrane biohybrid system using pig hepatocytes: Effect of diclofenac on cell biotransformation and synthetic functions. Journal of Membrane Science 278:1-2, pages 133-143.
Crossref
Crossref
Gina RohekarArthur AM Bookman. (2006) Diclofenac sodium in the treatment of osteoarthritis. Aging Health 2:2, pages 179-187.
Crossref
Crossref
Ihsan M. Kenawi. (2006) DFT analysis of diclofenac activity and cation type influence on the theoretical parameters of some diclofenac complexes. Journal of Molecular Structure: THEOCHEM 761:1-3, pages 151-157.
Crossref
Crossref
Meena Rani & Brahmeshwar Mishra. (2004) Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS PharmSciTech 5:4, pages 153-159.
Crossref
Crossref
Caroline D. Marel, Brian J. Anderson, Janne Romsing, Evelyne Jacqz-Aigrain & Dick Tibboel. (2004) Diclofenac and metabolite pharmacokinetics in children. Pediatric Anesthesia 14:6, pages 443-451.
Crossref
Crossref
M.José Gómez-Lechón, Xavier Ponsoda, Enrique O’Connor, Teresa Donato, José V. Castell & Ramiro Jover. (2003) Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochemical Pharmacology 66:11, pages 2155-2167.
Crossref
Crossref
JB Lyons, A Niazi, D Lowe, SJ Sheehan & J Moriarty. (2003) A prospective, randomised trial of preoperative rectal diclofenac: Are we closing the gate after the horse has gone?. Irish Journal of Medical Science 172:3, pages 112-114.
Crossref
Crossref
Sanjeev Kumar, Koppara Samuel, Ramaswamy Subramanian, Matthew P. Braun, Ralph A. Stearns, Shuet-Hing Lee Chiu, David C. Evans & Thomas A. Baillie. (2002) Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide. Journal of Pharmacology and Experimental Therapeutics 303:3, pages 969-978.
Crossref
Crossref
Benoît M. Lapointe, Jérôme Frenette & Claude H. Côté. (2002) Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion. Journal of Applied Physiology 92:5, pages 1995-2004.
Crossref
Crossref
Seng-Chung Liu & Tung-Hu Tsai. (2002) Determination of diclofenac in rat bile and its interaction with cyclosporin A using on-line microdialysis coupled to liquid chromatography. Journal of Chromatography B 769:2, pages 351-356.
Crossref
Crossref
M. Silvanto, M. Lappi & P. H. Rosenberg. (2002) Comparison of the opioid‐sparing efficacy of diclofenac and ketoprofen for 3 days after knee arthroplasty. Acta Anaesthesiologica Scandinavica 46:3, pages 322-328.
Crossref
Crossref
Afaf A. Mahgoub. (2002) Grapefruit juice potentiates the anti-inflammatory effects of diclofenac on the carrageenan-induced rat’s paw oedema. Pharmacological Research 45:1, pages 1-4.
Crossref
Crossref
Rainer Schindler. (2001) Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents. Lipids 36:5, pages 543-548.
Crossref
Crossref
Cuyue Tang, Magang Shou, Thomas H. Rushmore, Qin Mei, Punam Sandhu, Eric J. Woolf, Mark J. Rose, Alyssa Gelmann, Howard E. Greenberg, Inge De Lepeleire, Anne Van Hecken, Paul J. De Schepper, David L. Ebel, Jules I. Schwartz & A. David Rodrigues. (2001) In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics 11:3, pages 223-235.
Crossref
Crossref
Jennifer S. Lill, Teresa O'Sullivan, Larry A. Bauer, John H. Horn, Robert CarithersJr.Jr., D. Eugene Strandness, Henry Lau, Keith Chan & Kamlesh Thakker. (2013) Pharmacokinetics of Diclofenac Sodium in Chronic Active Hepatitis and Alcoholic Cirrhosis. The Journal of Clinical Pharmacology 40:3, pages 250-257.
Crossref
Crossref
Roque Bort, Katherine Macé, Alan Boobis, Marı́a-José Gómez-Lechón, Andrea Pfeifer & José Castell. (1999) Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochemical Pharmacology 58:5, pages 787-796.
Crossref
Crossref
G Giagoudakis & S.L Markantonis. (1998) An alternative high-performance liquid-chromatographic method for the determination of diclofenac and flurbiprofen in plasma. Journal of Pharmaceutical and Biomedical Analysis 17:4-5, pages 897-901.
Crossref
Crossref
D. BougieS.T. JohnsonL.A. WeitekampR.H. Aster. (1997) Sensitivity to a Metabolite of Diclofenac as a Cause of Acute Immune Hemolytic Anemia. Blood 90:1, pages 407-413.
Crossref
Crossref
D. BougieS.T. JohnsonL.A. WeitekampR.H. Aster. (1997) Sensitivity to a Metabolite of Diclofenac as a Cause of Acute Immune Hemolytic Anemia. Blood 90:1, pages 407-413.
Crossref
Crossref
J.O. Auler Jr.E.B. Espada, E. Crivelli, T.B.G. Quintavalle, A. Kurata, N.A.G. Stolf, A.M. Issy, O.E.D. Paschoa, M. Danhof, D.D. Breimer, D.A.F. Chamone & S.R.C.J. Santos. (1997) Diclofenac plasma protein binding: PK-PD modelling in cardiac patients submitted to cardiopulmonary bypass. Brazilian Journal of Medical and Biological Research 30:3, pages 369-374.
Crossref
Crossref
X. Ponsoda, R. Bort, R. Jover, M.J. Gómez-lechón & J.V. Castell. (1995) Molecular mechanism of diclofenac hepatotoxicity: Association of cell injury with oxidative metabolism and decrease in ATP levels. Toxicology in Vitro 9:4, pages 439-444.
Crossref
Crossref
Koichiro Tahara, Ken Yamamoto & Toshiaki Nishihata. (1995) Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. Journal of Controlled Release 35:1, pages 59-66.
Crossref
Crossref
L. Niemi, M. Tuominen, M. Pitkänen & P. H. Rosenberg. (2011) Comparison of parenteral diclofenac and ketoprofen for postoperative pain relief after maxillofacial surgery. Acta Anaesthesiologica Scandinavica 39:1, pages 96-99.
Crossref
Crossref
D. MANNION, C. ARMSTRONG, G. O'LEARY & W. CASEY. (2007) Paediatric post orchidopexy analgesia—effect of diclofenac combined with ilioinguinal/iliohypogastric nerve block. Pediatric Anesthesia 4:5, pages 327-330.
Crossref
Crossref
A. Sioufi, F. Pommier, F. Boschet, J. Godbillon, D. Lavoignat & D. Salliere. (2006) Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharmaceutics & Drug Disposition 15:6, pages 441-449.
Crossref
Crossref
D. J. Bush, G. Lyons & R. Macdonald. (1992) Diclofenac for analgesia after Caesarean section. Anaesthesia 47:12, pages 1075-1077.
Crossref
Crossref
J. Laitinen, L. S. Nuutinen, J. Puranen, P. Ranta & T. Salomäki. (2008) Effect of a non‐steroidal anti‐inflammatory drug, diclofenac, on haemostasis in patients undergoing total hip replacement. Acta Anaesthesiologica Scandinavica 36:5, pages 486-489.
Crossref
Crossref
J. Moncrieff. (1992) Extractionless determination of diclofenac sodium in serum using reversed-phase high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography B: Biomedical Sciences and Applications 577:1, pages 185-189.
Crossref
Crossref
J. Radermacher, D. Jentsch, MA Scholl, T. Lustinetz & JC Frolich. (1991) Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.. British Journal of Clinical Pharmacology 31:5, pages 537-541.
Crossref
Crossref
M.A. Moores, J.G. Wandless & D. Fell. (1990) Paediatric postoperative analgesia A comparison of rectal diclofenac with caudal bupivacaine after inguinal herniotomy. Anaesthesia 45:2, pages 156-158.
Crossref
Crossref
Christianah M. Adeyeye & Pui-Kai Li. 1990.
123
144
.
M Merle-MeletN SetaR FarinottiC Carbon. (1989) Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits. Antimicrobial Agents and Chemotherapy 33:9, pages 1506-1510.
Crossref
Crossref
A. D. Colquhoun & D. Fell. (2007) Failure of rectal diclofenac to augment opioid analgesia after cholecystectomy. Anaesthesia 44:1, pages 57-60.
Crossref
Crossref
Luigi Zecca & Paolo Ferrario. (1989) Determination of diclofenac in plasma and synovial fluid by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B: Biomedical Sciences and Applications 495, pages 303-308.
Crossref
Crossref
Vasilios A. Skoutakis, Charles A. Carter, Timothy R. Mickle, Valorie H. Smith, Charles R. Arkin, Jane Alissandratos & Daniel E. Petty. (2016) Review of Diclofenac and Evaluation of its Place in Therapy as a Nonsteroidal Antiinflammatory Agent. Drug Intelligence & Clinical Pharmacy 22:11, pages 850-859.
Crossref
Crossref
P. H. Degen. 1988. Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular. Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular
107
114
.
Keith K.H. Chan, Kunjbala H. Vyas & Kenneth D. Brandt. (1987) In Vitro Protein Binding of Diclofenac Sodium in Plasma and Synovial Fluid. Journal of Pharmaceutical Sciences 76:2, pages 105-108.
Crossref
Crossref
Susan G. Owen, Michael S. Roberts & William T. Friesen. (1987) Rapid high-performance liquid chromatographic assay for the simultaneous analysis of non-steroidal antiinflammatory drugs in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 416, pages 293-302.
Crossref
Crossref
L. S. Nuuttnen, E. Wuolijoki & I. T. Pentikäinen. (2008) Diclofenac and oxycodone in treatment of postoperative pain: a double‐blind trial. Acta Anaesthesiologica Scandinavica 30:8, pages 620-624.
Crossref
Crossref
Tohru Koide, Tadeusz W. Wieloch & Bo K. Siesjö. (2016) Chronic Dexamethasone Pretreatment Aggravates Ischemic Neuronal Necrosis. Journal of Cerebral Blood Flow & Metabolism 6:4, pages 395-404.
Crossref
Crossref
H. A. Bird, J. Hill, P. Leatham & V. Wright. (1986) A study to determine the clinical relevance of the pharmacokinetic interaction between aspirin and diclofenac. Agents and Actions 18:3-4, pages 447-449.
Crossref
Crossref
Alfred R. Sallmann. (1986) The history of diclofenac. The American Journal of Medicine 80:4, pages 29-33.
Crossref
Crossref
R Bettini, E Grossi, P Rapazzini & G Giardina. (2016) Diclofenac Sodium versus Acetylsalicylic Acid: A Randomized Study in Febrile Patients. Journal of International Medical Research 14:2, pages 95-100.
Crossref
Crossref
F. Plavsic & J. Čulig. (2016) Determination of Serum Diclofenac by High-performance Liquid Chromatography by Electromechanical Detection. Human Toxicology 4:3, pages 317-322.
Crossref
Crossref
Jean-Marie Chamouard, Jérôme Barre, Saïk Urien, Georges Houin & Jean-Paul Tillement. (1985) Diclofenac binding to albumin and lipoproteins in human serum. Biochemical Pharmacology 34:10, pages 1695-1700.
Crossref
Crossref
Shun-Ichi Naito & Hideharu Tominaga. (1985) Percutaneous absorption of diclofenac sodium ointment. International Journal of Pharmaceutics 24:1, pages 115-124.
Crossref
Crossref
J. Godbillon, S. Gauron & J.P. Metayer. (1985) High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. Journal of Chromatography B: Biomedical Sciences and Applications 338, pages 151-159.
Crossref
Crossref
N. Thumb. 1983. Rheumatologie A. Rheumatologie A
335
485
.
W. Schneider & P.H. Degen. (1981) Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection. Journal of Chromatography A 217, pages 263-271.
Crossref
Crossref
. (2005) Experimental models. Arthritis & Rheumatism 24:2, pages 315-442.
Crossref
Crossref
A. Schweizer, J.V. Willis, D.B. Jack & M.J. Kendall. (1980) Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography. Journal of Chromatography A 195:3, pages 421-424.
Crossref
Crossref
J. V. Willis, M. J. Kendall & D. B. Jack. (1980) A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium. European Journal of Clinical Pharmacology 18:5, pages 415-418.
Crossref
Crossref
P.D. FOWLER. (1979) Voltarol: Diclofenac Sodium. Clinics in Rheumatic Diseases 5:2, pages 427-464.
Crossref
Crossref
R. Menassé. (1979) Evaluation of ulcerogenic effects. Pharmacology & Therapeutics 5:1-3, pages 191-197.
Crossref
Crossref
J. V. Willis, M. J. Kendall, R. M. Flinn, D. P. Thornhill & P. G. Welling. (1979) The pharmacokinetics of diclofenac sodium following intravenous and oral administration. European Journal of Clinical Pharmacology 16:6, pages 405-410.
Crossref
Crossref